Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents.

× No keyword cloud information.

6 in total

1. Rituximab therapy for AA-amyloidosis secondary to rheumatoid arthritis.

Authors: Javier Narváez; Maria Victoria Hernández; José Miguel Ruiz; Carmen Gómez Vaquero; Xavier Juanola; Joan Miquel Nollaa
Journal: Joint Bone Spine Date: 2010-11-09 Impact factor: 4.929

2. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.

Authors: Yasuaki Okuda; Kiyoshi Takasugi
Journal: Arthritis Rheum Date: 2006-09

Review 3. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.

Authors: Laura Obici; Sara Raimondi; Francesca Lavatelli; Vittorio Bellotti; Giampaolo Merlini
Journal: Arthritis Rheum Date: 2009-10-15

4. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.

Authors: Tadashi Nakamura; Syu-ichi Higashi; Kunihiko Tomoda; Michishi Tsukano; Masahiro Shono
Journal: Clin Rheumatol Date: 2010-05-05 Impact factor: 2.980

5. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.

Authors: Jacques-Eric Gottenberg; Florence Merle-Vincent; Fabrice Bentaberry; Yannick Allanore; Francis Berenbaum; Bruno Fautrel; Bernard Combe; Antoine Durbach; Jean Sibilia; Maxime Dougados; Xavier Mariette
Journal: Arthritis Rheum Date: 2003-07

6. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.

Authors: T Nakamura; S Higashi; K Tomoda; M Tsukano; S Baba
Journal: Clin Exp Rheumatol Date: 2007 Jul-Aug Impact factor: 4.473

6 in total